We are live on
!
Find out more
SCM
Silverarc Capital Management Portfolio holdings
AUM
$849M
1-Year Est. Return
470.8%
This Fund
S&P 500
This Quarter
Est. Return
-5.15%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$213M
AUM Growth
+$213M
(+100,917%)
Cap. Flow
+$59.3M
Cap. Flow
% of AUM
27.8%
Top 10 Holdings %
Top 10 Hldgs %
50.55%
Holding
88
New
13
Increased
29
Reduced
15
Closed
19
Top Buys
| 1 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$9.77M |
| 2 |
Veracyte
VCYT
|
+$5.92M |
| 3 |
Oric Pharmaceuticals
ORIC
|
+$4.32M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$4.3M |
| 5 |
Xenon Pharmaceuticals
XENE
|
+$3.98M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$9.72M |
| 2 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$4.45M |
| 3 |
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
|
+$1.55M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$993K |
| 5 |
Immatics
IMTX
|
+$714K |
Sector Composition
| 1 | Healthcare | 98.78% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $17.9M | 8.4% |
313,962
+5,143
| +2% | +$292K |
|
|
BLU
2
DELISTED
BELLUS Health Inc.
BLU
| $14.4M | 6.77% |
1,562,957
+327,173
| +26% | +$2.68M |
|
|
3
Veracyte
VCYT
$4.75B
| $14.3M | 6.7% |
718,789
+293,235
| +69% | +$5.92M |
|
4
Cerus
CERS
$637M
| $11.1M | 5.19% |
2,093,861
+695,461
| +50% | +$3.47M |
|
|
MRUS
5
DELISTED
Merus
MRUS
| $10.6M | 4.98% |
469,113
+144,394
| +44% | +$3.01M |
|
|
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $9.09M | 4.26% |
418,660
+349,951
| +509% | +$9.77M |
|
|
CTIC
7
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $8.24M | 3.86% |
1,380,111
-869,889
| -39% | -$4.45M |
|
8
Aclaris Therapeutics
ACRS
$782M
| $7.53M | 3.53% |
539,545
+264,212
| +96% | +$3.7M |
|
9
Cogent Biosciences
COGT
$6.72B
| $7.41M | 3.47% |
820,954
+247,255
| +43% | +$1.69M |
|
|
SGEN
10
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.22M | 3.38% |
40,787
+29,831
| +272% | +$4.3M |
|
|
11
Xenon Pharmaceuticals
XENE
$6.55B
| $7.08M | 3.32% |
232,630
+131,549
| +130% | +$3.98M |
|
12
Krystal Biotech
KRYS
$10.3B
| $6.91M | 3.24% |
105,277
+58,788
| +126% | +$3.66M |
|
|
APLS
13
DELISTED
Apellis Pharmaceuticals
APLS
| $5.87M | 2.75% |
129,795
+24,427
| +23% | +$1.11M |
|
|
HZNP
14
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.76M | 2.7% |
72,187
+4,745
| +7% | +$449K |
|
|
15
Oric Pharmaceuticals
ORIC
$1.15B
| $4.85M | 2.27% |
+1,082,304
| New | +$4.32M |
|
16
Biogen
BIIB
$29.1B
| $4.25M | 1.99% |
20,825
+10,577
| +103% | +$2.16M |
|
17
Insmed
INSM
$23.8B
| $4.19M | 1.96% |
212,482
+110,415
| +108% | +$2.31M |
|
|
MRSN
18
DELISTED
Mersana Therapeutics
MRSN
| $3.93M | 1.84% |
+34,000
| New | +$3.2M |
|
|
APEN
19
DELISTED
Apollo Endosurgery, Inc.
APEN
| $3.92M | 1.84% |
1,074,879
+70,480
| +7% | +$333K |
|
|
BHVN
20
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.84M | 1.8% |
26,374
-76,123
| -74% | -$9.72M |
|
21
United Therapeutics
UTHR
$22.6B
| $3.82M | 1.79% |
16,227
+1,391
| +9% | +$283K |
|
|
22
Immatics
IMTX
$1.29B
| $3.09M | 1.45% |
355,103
-90,231
| -20% | -$714K |
|
23
Vertex Pharmaceuticals
VRTX
$121B
| $2.94M | 1.38% |
10,414
+2,776
| +36% | +$743K |
|
24
Cullinan Oncology
CGEM
$1.1B
| $2.73M | 1.28% |
+213,090
| New | +$2.42M |
|
25
Crinetics Pharmaceuticals
CRNX
$8.88B
| $2.6M | 1.22% |
139,539
+25,535
| +22% | +$510K |
|
Similar funds
BOTOTLSJU
LA
EPIMS
CFP
USAA
OMC
AIA
EBSAM